Theravance Biopharma, Inc.
USD15.92
+0.34 (+2.18%)
CEO
Rick E. Winningham
IPO Date
2014-05-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
KY
Open
$15.65
Prev. Close
$15.58
Day Low
$15.65
Day High
$16.18
52W Low
$10.42
52W High
$21.03
Market Cap
$0.82B
Volume
0.33M
| 8,670 |
| $16.55 |
| 22 May 2026 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | F-InKind | Disposed | 6,827 | $16.55 |
| 22 May 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F-InKind | Disposed | 8,829 | $16.55 |
| 22 May 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F-InKind | Disposed | 5,678 | $16.55 |
| 3 Apr 2026 | Winningham Rick E | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 75,000 | $0.00 |
| 3 Apr 2026 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | A-Award | Acquired | 37,500 | $0.00 |
| 3 Apr 2026 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | A-Award | Acquired | 37,500 | $0.00 |
| 3 Apr 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | A-Award | Acquired | 18,750 | $0.00 |
| 18 Mar 2026 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S-Sale | Disposed | 7,767 | $13.92 |